why choose us

First received: May 26, 2023

Clinical Trial: Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Oral Semaglutide 50 mg Once Daily in Chinese Adults With Overweight or Obesity (OASIS 3)

Brief Summary: This study is being conducted to see if semaglutide tablets can be used as a treatment to help people who are above a healthy weight range to lose weight.Semaglutide tablets are a new medicine being tested to treat people living with excess body weight.Participants will either get semaglutide or placebo once daily morning for 44 weeks.In addition to taking the medicine, participants will have talks with study staff about:Healthy food choicesHow to be more physically activeWhat participants can do to lose weight…

Read more